Research Pediatric Use
The safety of paediatric use of cannabidiol
The aim of this set of research is not to determine efficacy, but to determine if there is a dose/side effect profile in paediatric patients under the direct care of a consultant paediatrician.
Juveniles are often treated for the following conditions using cannabidiol containing products.
- Addison’s disease
- Celiac disease
- Crohn’s disease
- Juvenile dermatomyositis
- Juvenile idiopathic rheumatoid arthritis
- multiple sclerosis (MS)
- PANDAS (Pediatric Autoimmune Neuropsychiatric Disease Associated with Strep Infection)
- type-1 diabetes
- Ulcerative colitis